Literature DB >> 1919854

Telopeptide-depleted bovine skin collagen as a carrier for bone morphogenetic protein.

K Takaoka1, M Koezuka, H Nakahara.   

Abstract

The telopeptide of type I collagen is thought to be responsible for causing immunogenic response when introduced into xenogenic hosts. To eliminate this problem, solubilized bovine skin collagen was filtered through a millipore membrane, digested repeatedly with pepsin to remove telopeptides, and used as a carrier for a water-soluble, partially-purified fraction of bone morphogenetic protein (BMP) in mice. Composite implants of this telopeptide-depleted collagen and the partially-purified BMP fraction consistently elicited ectopic bone formation in mice 3 weeks postimplantation. When implanted alone, collagen or BMP failed to show this response. Collagens, prepared by use of conventional methods (acid-solubilized collagen, or collagen-digested once with pepsin) were also assessed as carriers for BMP, but were found to be inferior in terms of consistency of bone formation and amount of induced bone mass. The results suggest that telopeptide-depleted collagen permitted a gradual release of purified BMP for induction of bone, with minimal immunogenic interference. Consequently, this collagen carrier represents an important development for future clinical application of BMP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1919854     DOI: 10.1002/jor.1100090617

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  8 in total

Review 1.  Growth factor delivery: how surface interactions modulate release in vitro and in vivo.

Authors:  William J King; Paul H Krebsbach
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

Review 2.  Biotechnology and bone graft substitutes.

Authors:  R A Kenley; K Yim; J Abrams; E Ron; T Turek; L J Marden; J O Hollinger
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

3.  Stimulation of ectopic bone formation in response to BMP-2 by Rho kinase inhibitor: a pilot study.

Authors:  Hideki Yoshikawa; Kiyoko Yoshioka; Takanobu Nakase; Kazuyuki Itoh
Journal:  Clin Orthop Relat Res       Date:  2009-07-17       Impact factor: 4.176

4.  Enhancement of bone ingrowth in a titanium fiber mesh implant by rhBMP-2 and hyaluronic acid.

Authors:  S Itoh; M Matubara; T Kawauchi; H Nakamura; S Yukitake; S Ichinose; K Shinomiya
Journal:  J Mater Sci Mater Med       Date:  2001-07       Impact factor: 3.896

5.  Synthetic alginate is a carrier of OP-1 for bone induction.

Authors:  Katsuhiko Nanno; Kenjiro Sugiyasu; Takashi Daimon; Hideki Yoshikawa; Akira Myoui
Journal:  Clin Orthop Relat Res       Date:  2009-05-28       Impact factor: 4.176

6.  Sintered porous Ti6Al4V scaffolds incorporated with recombinant human bone morphogenetic protein-2 microspheres and thermosensitive hydrogels can enhance bone regeneration.

Authors:  Ji Li; Zhongli Li; Qi Wang; Yueyi Shi; Wei Li; Yangmu Fu; Gong Jin
Journal:  RSC Adv       Date:  2019-01-11       Impact factor: 4.036

7.  miR-29b-3p regulated osteoblast differentiation via regulating IGF-1 secretion of mechanically stimulated osteocytes.

Authors:  Qiangcheng Zeng; Yang Wang; Jie Gao; Zhixiong Yan; Zhenghua Li; Xianqiong Zou; Yanan Li; Jiahui Wang; Yong Guo
Journal:  Cell Mol Biol Lett       Date:  2019-03-14       Impact factor: 5.787

Review 8.  Craniofacial Bone Tissue Engineering: Current Approaches and Potential Therapy.

Authors:  Arbi Aghali
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.